Liposome@IR780 Nanoparticles for Efficient Sonodynamic Therapy to Treat Triple-negative Breast Cancer
Source abstract
Abstract
The hydrophobic sonosensitizer IR780 iodide (IR780) was loaded into liposomes to form Liposome@IR780 nanoparticles (NPs) for triple-negative breast cancer (TNBC) to enhance SDT via low-intensity ultrasound (LIU) irradiation. The NPs were characterized using various physicochemical methods including size distribution, zeta potential, and morphology.In vitroexperiments show that the Liposome@IR780 NPs can generate more reactive oxygen species (ROS) upon LIU irradiation. The apoptosis experiment results further demonstrate that Liposome@IR780 NPs show better apoptosis rate against 4T1 cells. Our results indicate that Liposome@IR780 NPs will provide a promising approach for TNBC upon SDT treatment.
Source: expertdata · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Ultrasound and Hyperthermia Applications · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (34)
Show source-provided references
1. Lu BY, Natarajan E, Raghavendran HRB, et al. Molecular Classification, Treatment, and Genetic Biomarkers in Triple-Negative Breast Cancer: A Review[J]. Technol. Cancer Res. T., 2023, 22: 15 330 338 221 145 24610.1177/15330338221145246 ↗
2. Borri F, Granaglia A. Pathology of Triple Negative Breast Cancer[J]. Semin. Cancer Biol., 2021, 72: 136–14510.1016/j.semcancer.2020.06.005 ↗
3. Abad MN, Calabuig-Farinas S, de Mena ML, et al. Update on Systemic Treatment in Early Triple Negative Breast Cancer[J]. Ther. Adv. Med. Oncol., 2021, 13: 1 758 835 920 986 74910.1177/1758835920986749 ↗
4. Riaz F. New Strategies for the Management of Triple-Negative Breast Cancer[J]. Curr. Opin. Obstet. Gyn., 2024, 36(1): 40–4410.1097/GCO.0000000000000927 ↗
5. Ali MA, Aiman W, Shah SS, et al. Efficacy and Safety of Pembrolizumab based Therapies in Triple-Negative Breast Cancer: A Systematic Review of Clinical Trials[J]. Crit. Rev. Oncol. Hemat., 2021, 157: 103 19710.1016/j.critrevonc.2020.103197 ↗
6. Li Y, Zhang HJ, Merkher Y, et al. Recent Advances in Therapeutic Strategies for Triple-Negative Breast Cancer[J]. J. Hematol. Oncol., 2022, 15(1): 12110.1186/s13045-022-01341-0 ↗
7. Dias CJ, Helguero L, Faustino MAF. Current Photoactive Molecules for Targeted Therapy of Triple-Negative Breast Cancer[J]. Molecules, 2021, 26(24): 7 64510.3390/molecules26247654 ↗
8. Ostasnka E, Aebisher D, Bartusik-Aebisher D. The Potential of Photodynamic Therapy in Current Breast Cancer Treatment Methodologies[J]. Biomed. Pharmacother., 2021, 137: 111 30210.1016/j.biopha.2021.111302 ↗
9. Dong CH, Yang P, Wang X, et al. Multifunctional Composite Nanosystems for Precise/Enhanced Sonodynamic Oxidative Tumor Treatment[J]. Bioconjug. Chem. 2022, 33(6): 1 035–1 04810.1021/acs.bioconjchem.1c00478 ↗
10. Hu CT, Hou B, Xie SL. Application of Nanosonosensitizer Materials in Cancer Sono-Dynamic Therapy[J]. RSC Advances, 2022, 12(35): 22 722–22 74710.1039/D2RA03786F ↗
11. Zhao PX, Deng YB, Xiang GY, et al. Nanoparticle-Assisted Sonosensitizers and Their Biomedical Applications[J]. Int. J. Nanomed., 2021, 16: 4 615–4 63010.2147/IJN.S307885 ↗
12. Wu N, Fan CH, Yeh CK. Ultrasound-Activated Nanomaterials for Sonodynamic Cancer Theranostics[J]. Drug Discov. Today, 2022, 27(6): 1 590–1 60310.1016/j.drudis.2022.02.025 ↗
13. Uddin SMZ, Komatsu DE, Motyka T, et al. Low-Intensity Continuous Ultrasound Therapies-A Systematic Review of Current State-of-The-Art and Future Perspectives[J]. J. Clin. Med., 2021, 10(12): 2 69810.3390/jcm10122698 ↗
14. Wan GY, Liu Y, Chen BW, et al. Recent Advances of Sonodynamic Therapy in Cancer Treatment[J]. Cancer Biol. Med., 2016, 13(3): 325–33810.20892/j.issn.2095-3941.2016.0068 ↗
15. Ji XY, Duan H, Wang S, et al. Low-Intensity Pulsed Ultrasound in Obstetrics and Gynecology: Advances in Clinical Application and Research Progress[J]. Front. Endocrinol., 2023, 14: 1 233 18710.3389/fendo.2023.1233187 ↗
16. Panzone J, Byler T, Bratslavsky G, et al. Applications of Focused Ultrasound in the Treatment of Genitourinary Cancers[J]. Cancers, 2022, 14(6): 1 53610.3390/cancers14061536 ↗
17. Lin BW, Du H, Fan JJ, et al. Radioimmunotherapy Combined with Low-Intensity Ultrasound and Microbubbles: A Potential Novel Strategy for Treatment of Solid Tumors[J]. Front. Oncol., 2021, 11: 750 74110.3389/fonc.2021.750741 ↗
18. Zhou HY, Chen Y, Li P, He XX, et al. Sonodynamic Therapy for Breast Cancer: A Literature Review[J]. Open Chem., 2022, 20(1): 1 045–1 05610.1515/chem-2022-0186 ↗
19. Li L, Lin HR, Li DF, et al. Ultrasound Activated Nanosensitizers for Sonodynamic Therapy and Theranostics[J]. Biomed. Mater., 2021, 16(2): 022 00810.1088/1748-605X/abd382 ↗
20. Xu MM, Zhou LQ, Zheng L, et al. Sonodynamic Therapy-Derived Multimodal Synergistic Cancer therapy[J]. Cancer Lett., 2021, 497: 229–24210.1016/j.canlet.2020.10.037 ↗
21. Li JL, Yue ZY, Tang ML, et al. Strategies to Reverse Hypoxic Tumor Microenvironment for Enhanced Sonodynamic Therapy[J]. Adv. Healthc. Mater., 2024, 13 (1): 2 302 02810.1002/adhm.202302028 ↗
22. Hu HY, Zhao JH, Ma KZ, et al. Sonodynamic Therapy Combined with Phototherapy: Novel Synergistic Strategy with Superior Efficacy for Antitumor and Antiinfection Therapy[J]. J. Control. Release, 2023, 359: 188–20510.1016/j.jconrel.2023.05.041 ↗
23. Capistrano G, Sousa AA, Silva RA, et al. IR-780-Albumin-Based Nanocarriers Promote Tumor Regression not only from Phototherapy but Also by a Nonirradiation Mechanism[J]. ACS Biomater.-Sci. Eng., 2020, 6(8): 4 523–4 53810.1021/acsbiomaterials.0c00164 ↗
24. Ghosh A, Rajdev B, Parihar N, et al. Bio-Nanoconjugates of Lithocholic Acid/IR 780 for ROS-Mediated Apoptosis and Optoacoustic Imaging Applications in Breast Cancer[J]. Colloid. Surface. B, 2023, 221: 113 02310.1016/j.colsurfb.2022.113023 ↗
25. Wang L, Niu CC. IR780-Based Nanomaterials for Cancer Imaging and Therapy[J]. J. Mater. Chem. B, 2021, 9: 4 079–4 09710.1039/D1TB00407G ↗
26. Zhang L, Wang D, Yang K, et al. Mitochondria-Targeted Artificial “Nano-RBCs” for Amplified Synergistic Cancer Phototherapy by a Single NIR Irradiation[J]. Adv. Sci., 2018, 5: 1 800 04910.1002/advs.201800049 ↗
27. Li YK, Zhou QF, Deng ZT, et al. IR-780 Dye As A Sonosensitizer for Sonodynamic Therapy of Breast Tumor[J]. Sci. Rep., 2016, 6: 1–1010.1038/s41598-016-0001-8 ↗
28. Shen CX, Yue XF, Dai LY, et al. Hyperbaric Oxygen Enhanced the Chemotherapy of Mitochondrial Targeting Molecule IR-780 in Bladder Cancer[J]. J. Cancer Res. Clin., 2023, 149(2): 683–69910.1007/s00432-022-04385-4 ↗
29. Bukhari SI, Imam SS, Ahmad MZ, et al. Recent Progress in Lipid Nanoparticles for Cancer Theranostics: Opportunity and Challenges[J]. Pharmaceuticals, 2021, 13: 84010.3390/pharmaceutics13060840 ↗
30. Li YB, Yang J, Sun XL. Reactive Oxygen Species-Based Nanomaterials for Cancer Therapy[J]. Front. Chem., 2021, 9: 650 58710.3389/fchem.2021.650587 ↗
31. Zhang LZ, Zhu CY, Huang RT, et al. Mechanisms of Reactive Oxygen Species Generated by Inorganic Nanomaterials for Cancer Therapeutics[J]. Front. Chem., 2021, 9: 630 96910.3389/fchem.2021.630969 ↗
32. Mungur R, Zheng JS, Wang B, et al. Low-Intensity Focused Ultrasound Technique in Glioblastoma Multiforme Treatment[J]. Front. Oncol., 2022, 12: 903 05910.3389/fonc.2022.903059 ↗
33. Snehota M, Vachutka J, Haar ter G, et al. Therapeutic Ultrasound Experiments in Vitro: Review of Factors Influencing Outcomes and Reproducibility[J]. Ultrasonics, 2020, 107: 106 16710.1016/j.ultras.2020.106167 ↗
34. Hu CT, Hou B, Xie SL. Application of Nanosonosensitizer Materials in Cancer Sono-Dynamic Therapy[J]. RSC Advances, 2022, 12: 22 722–22 74710.1039/D2RA03786F ↗